Marisa Orrù

No ORCID on file · 6 papers in corpus · active 2001-2016

Study types

  • article 5
  • review 1

Condition tags

  • endometriosis 3
  • bladder_endometriosis 2
  • mesh:D004715 1
review 2016
Overview of elagolix for the treatment of endometriosis
Expert opinion on drug metabolism & toxicology ·doi:10.1517/17425255.2016.1171316

INTRODUCTION: Suppression of sex-steroid secretion is required in a variety of gynecological conditions. This can be achieved using gonadotropin releasing hormone (GnRH) agonists that bind pituitary gonadotropin receptors and antagonize the…

article 2015
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation
·doi:10.3109/09513590.2015.1079175

In the menopausal transition (MT), combined oral contraceptive (COC) should be chosen accordingly to its neutrality on liver metabolism and to its ability to counter the increase of fat mass (FM) that occurs in this reproductive period of l…

article 2015
Ultrasound in the Diagnosis of Deep Endometriosis 15 Ultrasound in the Diagnosis of Deep

Deep pelvic endometriosis is defined as subperitoneal infiltration of endometrial implants in the uterosacral ligaments, rectum, rectovaginal septum, vagina, or bladder. Although laparoscopy and biopsy remain the gold standard for diagnosis…

article 2013
The 12-month treatment with the oral contraceptiveformulation containing dienogest (DNG) andestradiol valerate (E2V) shows beneficial effects onpsychological symptoms: results from aprospective comparative study with a formulationcontaining ethinyl estradiol (EE) and drospirenone(DRSP)

The COCs evolution has been obtained with new and differents progestinic compounds associated with lower doses of EE (ethinylestradiol). The revolution in the COCs field is the introduction of estradiol valerate (E2V), ester of the natural …

article 2009
Ultrasound in the Diagnosis of Deep Endometriosis
·doi:10.5005/jp-journals-10009-1004

Abstract Deep pelvic endometriosis is defined as subperitoneal infiltration of endometrial implants in the uterosacral ligaments, rectum, rectovaginal septum, vagina, or bladder. Although laparoscopy and biopsy remain the gold standard for …

article 2001
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy
·doi:10.1097/00042192-200111000-00007

OBJECTIVE: To evaluate the effectiveness of vaginal danazol as progestin supplement to estrogen replacement therapy, and its interference with uterine and carotid artery flow compared with medroxyprogesterone-acetate (MPA), estrogen alone, …